BeStock  

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2408Drug Manufacturers - Specialty & Generic
$16.97 +$0.35 (+2.11%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.00 +0.18%
Open$16.61
Prev close$16.62
Day range$16.53 – $17.04
Volume2.86M
Market cap$3.10B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

XERS at a glance

Xeris Pharmaceuticals (XERS) is trading at $16.97, up 2.11% on the day. Its market value of $3.10B makes it the 2408th largest of the 3753 companies we follow.

The stock's 52-week band runs $5.25 to $17.28, and the latest print sits 1.8% under the top end of it. Holders are ahead 148.5% over twelve months, and up 94.2% across the last three months.

On the chart it holds above both the 50-day ($11.29) and 200-day ($8.07) moving averages; RSI is 82, which some call overbought, and the last 30 sessions moved at roughly 87% annualized volatility.

Revenue for the quarter ended Sep 2026 was $107.23M, up 44.2% from a year earlier, with $11.29M of net profit (a -1.8% margin).

6 analysts follow the stock and the average call is "buy". The mean target, $16.50, sits 2.8% under where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$16.94 / $17.00
Average price today$16.82
Volume2.86MAvg (90d) 2.53M
Turnover$48.05M
Turnover rate1.62%of shares outstanding
Volume ratio1.01vs. recent average pace
Day amplitude3.04%
Market cap$3.10B
Float market cap$3.00B
Shares outstanding176.52M
EPS (TTM)$0.00
P/B63.56
Book value / share$0.27
Net profit (TTM)$548,100.11
Net assets$48.78M
30-day volatility86.7%annualized
Avg daily range (ATR)5.27%of price, 14 days
Max drawdown (1y)-34.9%-0.1% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

A
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

A
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

6 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 19.2 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation2.3
Growth—
Profitability31.8
Momentum99.8
Financial health45.6
Analyst view28.0

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$16.50-2.8% vs. current price
Consensus ratingBuy6 analysts covering
Morningstar fair value$13.26Price is above fair value

Wall Street’s average 12-month target is $16.50, 2.8% below today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $13.26, so shares trade 28.0% above that estimate. On earnings multiple, it sits in the 0th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
+2.1%
1 week
+1.9%
1 month
+56.3%
3 months
+94.2%
6 months
+174.2%
Year to date
+116.2%
1 year
+148.5%
Day range
$16.53$17.04
52-week range
$5.25$17.28

Technical signals

Full technicals →
Trend readStrong uptrend

6 bullish · 0 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average+22.3%Bullish
Price vs 50-day average+50.3%Bullish
Price vs 200-day average+110.3%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)81.7Neutral
MACD (12,26,9)1.82Bullish
Bollinger band position76%Bullish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How XERS ranks on BeStock

Market value#2398 of 3734
Closeness to 52-week high#60 of 3724
Dollar volume today#1447 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

XERS is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on XERS.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on XERS

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

XERS stock: common questions

What is XERS's latest share price?

$16.97 is the latest print for XERS, a move of +2.11% against yesterday's close of $16.62. Today's low and high so far: $16.53 and $17.04.

What is XERS worth in total?

Equity value comes to $3.10B at the current price. By that measure it is number 2408 of the 3753 names in our coverage.

Where does XERS sit in its 52-week range?

The year's floor is $5.25 and the ceiling $17.28. Shares are 1.8% away from that ceiling.

Does XERS send cash back through a dividend?

Our data shows no dividend paid by Xeris Pharmaceuticals over the trailing twelve months.

Do Wall Street analysts like XERS?

Of 6 analysts, 83% say buy, 17% hold and 0% sell. Price targets average $16.50, with the most cautious at $8.00 and the most optimistic at $21.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on XERS.

Sign in to join the discussion.

Scroll to Top